[go: up one dir, main page]

Atkinson, 1996 - Google Patents

Mechanisms of lysis by cytotoxic T cells

Atkinson, 1996

View PDF
Document ID
10540554844620976708
Author
Atkinson E
Publication year

External Links

Snippet

Cytotoxic T lymphocytes (CTL) kill their target cells in one of two ways. Tumour and virus infected cells are eliminated by exocytosing the contents of CTL cytolytic granules towards them in a calcium dependent process. Notable granule proteins involved in causing the …
Continue reading at era.library.ualberta.ca (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects

Similar Documents

Publication Publication Date Title
Atkinson et al. Mechanisms of lysis by cytotoxic T cells
Chu et al. Systematic identification of regulatory proteins critical for T-cell activation
Chang et al. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease
ES2210260T3 (en) METHOD OF MARKING OF EUCARIOTIC CELLS USING A CELL SURFACE RECEIVER AS A MARKER.
Radoja et al. T-cell receptor signaling events triggering granule exocytosis
US7488587B2 (en) Histone deacetylase and methods of use thereof
Berke et al. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes
Makino et al. Extrathymic differentiation of a T cell bearing invariant Vα14Jα281 TCR
Naper et al. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands
Lee et al. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis
US7118854B2 (en) PAK2: modulators of lymphocyte activation
Atkinson Mechanisms of lysis by cytotoxic T cells
WO1999026980A1 (en) Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
Horta et al. Resistance of effector cells to perforin-mediated cytolysis
Griffiths et al. Pathways for cytolysis
US20020064855A1 (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
WO2003062272A1 (en) Novel strategy for modulating t cell activation which is based on regulating the cd3ε - nck interaction
Vrban et al. LPAR5–GPCR modulation of human CD8+ T cell activation
Favre et al. Fas (CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection
Hills Novel Regulatory Mechanisms of Foxo1-Dependent Transcription, CD8 T Cell Memory and Survival
Jiang Molecular regulation of thymocyte survival and apoptosis in murine T cell development
Fang Molecular analysis ofbcl-x in B lymphocyte development
US20020146747A1 (en) TRAC1: modulators of lymphocyte activation
Bochan Granzyme B is an essential component for DNA fragmentation and target cell lysis mediated by human NK cells
Smith Expression, function and ligands for the Ly-49H NK cell activation receptor